Literature DB >> 16169290

Respiratory factors do not limit maximal symptom-limited exercise in patients with mild cystic fibrosis lung disease.

Jonathan D Dodd1, Sinead C Barry, Charles G Gallagher.   

Abstract

To evaluate whether respiratory factors limit exercise capacity in patients with mild cystic fibrosis (CF) lung disease (mean FEV(1) = 76 +/- 7.7% predicted) we stressed the respiratory system of seven patients using added dead space (V(D)). Primary outcomes were exercise duration (Ex(dur)) and maximal oxygen uptake (VO(2max)). Dyspnoea/leg-discomfort were assessed at end-exercise. Ex(dur) was identical between control and V(D) studies (520 +/- 152 versus 511 +/ -166 s, p = NS) as was VO(2max)(1.6 +/- 0.5 versus 1.6 +/- 0.6 L/min, p = NS). Significant resting, sub-maximal and maximal workload increases in minute ventilation (V(E)) were detected (70.8 +/- 13.7 versus 79.5 +/- 16.9 L/min, p < 0.05). Analysis of breathing pattern revealed increases in V(E) were attributable to increases in tidal volume (2.0 +/- 0.5 versus 2.2 +/- 0.6 L, p < 0.05) with no change in respiratory frequency. There was no difference in dyspnoea/leg discomfort between tests. The increase in V(E) in response to V(D), with no change in [Exdur/VO(2max) suggests maximal symptom-limited exercise limitation is not primarily limited by respiratory factors in mild CF lung disease. Focused investigation and treatment of non-respiratory factors contributing to exercise limitation may improve exercise rehabilitation in this patient group.

Entities:  

Mesh:

Year:  2005        PMID: 16169290     DOI: 10.1016/j.resp.2005.08.003

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  3 in total

1.  Cardiorespiratory and sensory responses to exercise in adults with mild cystic fibrosis.

Authors:  Bradley S Quon; Sabrina S Wilkie; Yannick Molgat-Seon; Michele R Schaeffer; Andrew H Ramsook; Pearce G Wilcox; Jordan A Guenette
Journal:  J Appl Physiol (1985)       Date:  2015-10-01

2.  Do patient-reported outcomes have a role in the management of patients with cystic fibrosis?

Authors:  M Sam Salek; S Jones; M Rezaie; C Davies; R Mills; R I Ketchell
Journal:  Front Pharmacol       Date:  2012-03-12       Impact factor: 5.810

3.  Ventilatory response to exercise in adolescents with cystic fibrosis and mild-to-moderate airway obstruction.

Authors:  Bart C Bongers; Maarten S Werkman; Tim Takken; Erik H J Hulzebos
Journal:  Springerplus       Date:  2014-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.